European Archives - Page 62 of 986 - European Medical Journal

31 Oct 2024

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.

Declining Fertility Rates in England and Wales

Women in England and Wales had an average of 1.44 children between 2022 and 2023 according to data published by the Office for National Statistics, the lowest rate on record.

Stereotactic Body Radiotherapy Proven Effective for Localised Prostate Cancer

A recent phase 3 trial has demonstrated that stereotactic body radiotherapy (SBRT) is a viable treatment for localised prostate cancer…

Prophylactic Antibiotic Linked to Emergence of Superbug

A major international study has linked rifaximin with the global rise of a multidrug-resistant bacterial pathogen.

ACG Updates Guidelines for Management of Helicobacter Pylori

The American College of Gastroenterology (ACG) has issued a new clinical guideline to help healthcare providers more effectively manage Helicobacter pylori….

Clear Skin Ahead: Upadacitinib Shows Promise for Teens Battling Atopic Dermatitis

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to improve management of this chronic condition.

ER+/HER2- Metastatic Breast Cancer – Treatment after ET + CDK4/6i

Menarini Stemline’s key symposium from the 2024 European Society for Medical Oncology (ESMO) Congress, focused on treatment strategies…

31 Oct 2024

Under the Lens: Progression of Diabetic Retinopathy and the Impact of Fenofibrate

With an increasing prevalence of diabetic retinopathy, a cause of vision impairment and blindness in those with diabetes, there is a need…

AML Expert-Led Webinar: Exploring Maintenance Approaches in AML

Watch Part 2 of the Expert Webinar series on acute myeloid leukaemia (AML) maintenance therapy (catch up on Part 1 of the…

Spoonful of Technology: Sept-Oct

Take a look at the latest examples of how pharma and its partners are working together to develop technology to solve key challenges.